Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04165577 · ClinicalTrials.gov registry record · NA
Modulating Prefrontal Circuits Underlying Behavioral Flexibility in OCD: A TMS Study
A NA study, sponsored by Butler Hospital.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT04165577: Completed NA study, sponsored by Butler Hospital.
NCT04165577 is a NA study that has completed, run by Butler Hospital. The registered enrollment target is 68 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04165577, a NA study, has completed, sponsored by Butler Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
This study investigates whether slow-frequency repetitive transcranial magnetic stimulation targeting frontal pole can acutely modulate brain circuits which show abnormal functioning during behavioral flexibility in obsessive-compulsive disorder, as well as performance on a behavioral task.
Primary Outcome
Resting-state functional connectivity with ventral striatum (assessed via fMRI)
Interventions
- DEVICE sham rTMS
- DEVICE rTMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2019-11-15 |
| Est. Completion | 2022-12-02 |
| Phase | NA |
What the finished NCT04165577 record still lists
NCT04165577 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which sham rTMS is the first listed.
NCT04165577 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04165577 about?
NCT04165577 is a clinical study titled "Modulating Prefrontal Circuits Underlying Behavioral Flexibility in OCD: A TMS Study". This study investigates whether slow-frequency repetitive transcranial magnetic stimulation targeting frontal pole can acutely modulate brain circuits which show abnormal functioning during behavioral flexibility in obsessive-compulsive disorder, as well as performance on a behavioral task.
What is the current status of trial NCT04165577?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2019-11-15. Estimated completion is 2022-12-02.
What interventions are being tested in trial NCT04165577?
The interventions under investigation include: sham rTMS (DEVICE), rTMS (DEVICE).
Who is sponsoring clinical trial NCT04165577?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04165577's enrollment target sits among peer trials
68 1133rd of 2000 higher than 862 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI